Korea Investment CORP bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the second quarter, Holdings Channel reports. The firm bought 99,629 shares of the company’s stock, valued at approximately $38,844,000.
A number of other hedge funds also recently bought and sold shares of the company. BlackRock Inc. acquired a new position in shares of HCA Healthcare during the 2nd quarter worth about $5,069,974,000. State Street Corp increased its position in shares of HCA Healthcare by 1.0% during the fourth quarter. State Street Corp now owns 7,566,643 shares of the company’s stock valued at $3,532,563,000 after purchasing an additional 76,039 shares during the period. Capital World Investors raised its stake in shares of HCA Healthcare by 0.8% in the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock valued at $2,334,040,000 after purchasing an additional 40,086 shares in the last quarter. Geode Capital Management LLC boosted its stake in HCA Healthcare by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after buying an additional 13,565 shares in the last quarter. Finally, Norges Bank bought a new stake in HCA Healthcare in the fourth quarter valued at about $1,262,513,000. 62.73% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on the company. Cantor Fitzgerald decreased their price objective on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a report on Tuesday, July 7th. Stephens cut their target price on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Oppenheimer lowered their price target on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research report on Monday, July 27th. Leerink Partners reduced their target price on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Finally, Royal Bank Of Canada reiterated an “outperform” rating and set a $435.00 target price on shares of HCA Healthcare in a research report on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $462.64.
HCA Healthcare Price Performance
HCA stock opened at $429.08 on Friday. The business has a fifty day moving average price of $397.16 and a 200 day moving average price of $444.14. The stock has a market capitalization of $92.90 billion, a price-to-earnings ratio of 14.36, a P/E/G ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. During the same period last year, the company posted $6.84 earnings per share. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. On average, equities analysts expect that HCA Healthcare, Inc. will post 29.47 earnings per share for the current fiscal year.
HCA Healthcare Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is 10.45%.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Recommended Stories
- Five stocks we like better than HCA Healthcare
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
